FB
Factor Bioscience LLC
SEC filingBiotechnology · Cambridge, MA
Amount raised$1Msold at filing
Total offering$5M$4M still open
Investors in the raise1count reported to the SEC
FiledSep 25, 2025first sale Sep 15, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Matthew AngelExecutive Officer, Director
Christopher RohdeDirector
Executive officers, directors and promoters as listed on the Form D.